BIOTEST AG (BIO.DE) Stock Cash Flow
FRA:BIO - Deutsche Boerse Ag - DE0005227201 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | N/A | 127.00M | -31.70M | -62.70M | -30.00M | |||
| Depreciation Amortization | N/A | 35.90M | 35.80M | 31.10M | 29.60M | |||
| Change In Working Capital | 119.30M | -156.70M | -60.30M | 48.00M | -41.30M | |||
| Interest Paid | 32.20M | 24.20M | 13.10M | 12.80M | 6.60M | |||
| Taxes Paid | N/A | 11.70M | 2.00M | 900.00K | 2.00M | |||
| Other non cash items | N/A | -8.90M | 15.70M | 17.50M | 25.00M | |||
| OPERATING CASH FLOW | 119.30M | -2.70M | -40.50M | 33.90M | -16.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -33.40M | -29.30M | -18.20M | -27.00M | |||
| Other Investing Activity | -32.60M | 34.70M | -7.70M | -5.20M | 12.40M | |||
| INVESTING CASH FLOW | -32.60M | 1.30M | -37.00M | -23.40M | -14.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -8.90M | 94.20M | 19.80M | 42.70M | |||
| Dividend Paid | N/A | 0.00 | -800.00K | -800.00K | -800.00K | |||
| Other Financing Activity | -78.50M | 2.10M | -3.80M | 3.60M | 100.00K | |||
| FINANCING CASH FLOW | -78.50M | -6.80M | 89.60M | 22.60M | 42.00M | |||
| Exchange Rate Effect | 200.00K | 100.00K | 0.00 | 0.00 | -200.00K | |||
| CHANGE IN CASH | 8.40M | -8.10M | 12.10M | 33.10M | 10.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 119.30M | -2.70M | -40.50M | 33.90M | -16.70M | |||
| Capital Expenditure | N/A | -33.40M | -29.30M | -18.20M | -27.00M | |||
| FREE CASH FLOW | 119.30M | -36.10M | -69.80M | 15.70M | -43.70M | |||
All data in EUR